Insera earns CE Mark approval for cyclical-suction stroke thrombectomy platform, the CLEAR aspiration system

Insera earns CE Mark approval for cyclical-suction stroke thrombectomy platform, the CLEAR aspiration system

Press releases may be edited for formatting or style | April 09, 2019 Cardiology

“CLEAR’s proprietary power electronics technology for vacuum aspiration allows for the customization of both uniform and variable suction pressures within the safe vacuum suction range, all with an eye towards improving complete clot ingestion and a higher first-pass effect,” explained Vikram Janardhan, CEO of Insera Therapeutics, Inc.


About Insera

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.


Insera Therapeutics, Inc. is an ISO 13485 certified medical device company focused on treatments for vascular diseases including stroke. CLEARTM stands for Customizable, Luminal, Evacuation, Aspiration, and Retrieval. The CLEARTM Aspiration System is currently not cleared to market in the United States. InseraTM, CLEARTM, and CLEARTM Aspiration System are trademarks of Insera Therapeutics, Inc.


About the Jacobs Institute
The Jacobs Institute is a non-profit organization whose mission is to accelerate the development of next- generation technologies in vascular medicine through collisions of physicians, engineers, entrepreneurs, and industry. The JI's vision is to improve the treatment of vascular disease in Western New York and the world, while fostering local economic development. The JI fosters medical collaboration and innovation through partnerships with the University at Buffalo (UB), Kaleida Health, and industry, to be a fitting tribute to the work and memory of Lawrence D. Jacobs, M.D.


About New England Center for Stroke Research
NECStR is an image-guided surgery facility based within the University of Massachusetts Medical School that offers the latest technology in intervention to support investigators in developing minimally invasive treatments. NECStR has been fully operational since 2006. The center’s expertise and resources enable in vitro and animal modeling of vascular pathologies, multi-modal imaging, post-acquisition image processing, rapid prototyping from medical imaging and image-guided minimally invasive surgery.

Back to HCB News

You Must Be Logged In To Post A Comment